Molecular cloning of feline Fas antigen and Fas ligand cDNAs

Veterinary Immunology and Immunopathology

Volumn 65, Issue 2-4, 1998, Pages 161-172

  Mizuno, Takuya ^a   Endo, Yasuyuki ^a   Momoi, Yasuyuki ^a   Goto, Yuko ^a   Nishimura, Yoshiaki ^a   Tsubota, Kenjiro ^a   Mikami, Takeshi ^a   Ohno, Ko Ichi ^b   Watari, Toshihiro ^a   Tsujimoto, Hajime ^a   Hasegawa, Atsuhiko ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b YAMAGUCHI UNIVERSITY   (Japan)

Author keywords

Cat; Fas antigen; Fas ligand; Molecular cloning

Indexed keywords

COMPLEMENTARY DNA; FAS ANTIGEN; FAS LIGAND; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

AMINO ACID SEQUENCE; ANIMAL CELL; APOPTOSIS; CAT; CATTLE; CONFERENCE PAPER; CONTROLLED STUDY; HUMAN; LYMPHOMA CELL LINE; MOLECULAR CLONING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD95; APOPTOSIS; BASE SEQUENCE; CATS; CATTLE; CLONING, MOLECULAR; DNA PRIMERS; DNA, COMPLEMENTARY; FAS LIGAND PROTEIN; HUMANS; LIGANDS; MEMBRANE GLYCOPROTEINS; MICE; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY, AMINO ACID; TUMOR CELLS, CULTURED;

EID: 0032561148     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-2427(98)00151-2     Document Type: Conference Paper

References (48)

1. Alms W.J., Atamas S.P., Yurovsky V.V., White B. Generation of a variant of human interleukin-4 by alternative splicing. Mol. Immunol. 33:1996;361-370.
2. Badley A.D., McElhinny J.A., Leibson P.J., Lynch D.H., Alderson M.R., Paya C.V. Upregulation of Fas ligand expression by human immunodeficiency virus in human macrophages mediates apoptosis of uninfected T lymphocytes. J. Virol. 70:1996;199-206.
3. Boldin M.P., Varfolomeev E.E., Pancer Z., Mett I.L., Camonis J.H., Wallach D. A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J. Biol. Chem. 270:1995;7795-7798.
4. Cascino I., Fiucci G., Papoff G., Ruberti G. Three functional soluble forms of the human apoptosis-inducing Fas molecule are produced by alternative splicing. J. Immunol. 154:1995;2706-2713.
5. Cascino I., Papoff G., De Maria R., Testi R., Ruberti G. Fas/Apo-1 (CD95) receptor lacking the intracytoplasmic signaling domain protects tumor cells from Fas-mediated apoptosis. J. Immunol. 156:1996;13-17.
6. Cheng J., Zhou T., Liu C., Shapiro J.P., Brauer M.J., Kiefer M.C., Barr P.J., Mountz J.D. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science. 263:1994;1759-1762.
7. Chinnaiyan A.M., O'Rourke K., Tewari M., Dixit V.M. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell. 81:1995;505-512.
8. Chlichlia K., Busslinger M., Peter M.E., Walczak H., Krammer P.H., Schirrmacher V., Khazaie K. ICE-proteases mediate HTLV-I tax-induced apoptotic T-cell death. Oncogene. 14:1997;2265-2272.
9. Chlichlia K., Moldenhauer G., Daniel P.T., Busslinger M., Gazzolo L., Schirrmacher V., Khazaie K. Immediate effects of reversible HTLV-1 tax function: T-cell activation and apoptosis. Oncogene. 10:1995;269-277.
10. Ellis R.E., Yuan J.Y., Horvitz H.R. Mechanisms and functions of cell death. Annu. Rev. Cell. Biol. 7:1991;663-698.
11. Estaquier J., Tanaka M., Suda T., Nagata S., Golstein P., Ameisen J.C. Fas-mediated apoptosis of CD4+ and CD8+ T cells from human immunodeficiency virus-infected persons: differential in vitro preventive effect of cytokines and protease antagonists. Blood. 87:1996;4959-4966.
12. Fisher G.H., Rosenberg F.J., Straus S.E., Dale J.K., Middleton L.A., Lin A.Y., Strober W., Lenardo M.J., Puck J.M. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell. 81:1995;935-946.
13. Golstein P., Ojcius D.M., Young J.D. Cell death mechanisms and the immune system. Immunol. Rev. 121:1991;29-65.
14. Haagmans B.L., Egberink H.F., Horzinek M.C. Apoptosis and T-cell depletion during feline infectious peritonitis. J. Virol. 70:1996;8977-8983.
15. Horiuchi S., Koyanagi Y., Zhou Y., Miyamoto H., Tanaka Y., Waki M., Matsumoto A., Yamamoto M., Yamamoto N. Soluble interleukin-6 receptors released from T cell or granulocyte/macrophage cell lines and human peripheral blood mononuclear cells are generated through an alternative splicing mechanism. Eur. J. Immunol. 24:1994;1945-1948.
16. Hughes D.P., Crispe I.N. A naturally occurring soluble isoform of murine Fas generated by alternative splicing. J. Exp. Med. 182:1995;1395-1401.
17. Ikeda Y., Itagaki S., Tsutsui S., Inoshima Y., Fukasawa M., Tomonaga K., Tohya Y., Maeda K., Mochizuki M., Miyazawa T., Mikami T. Replication of feline syncytial virus in feline T-lymphoblastoid cells and induction of apoptosis in the cells. Microbiol. Immunol. 41:1997;431-435.
18. Itoh N., Nagata S. A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen. J. Biol. Chem. 268:1993;10932-10937.
19. Itoh N., Tsujimoto Y., Nagata S. Effect of bcl-2 on Fas antigen-mediated cell death. J. Immunol. 151:1993;621-627.
20. Itoh N., Yonehara S., Ishii A., Yonehara M., Mizushima S., Sameshima M., Hase A., Seto Y., Nagata S. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell. 66:1991;233-243.
21. Katsikis P.D., Wunderlich E.S., Smith C.A., Herzenberg L.A., Herzenberg L.A. Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals. J. Exp. Med. 181:1995;2029-2036.
22. Liu C., Cheng J., Mountz J.D. Differential expression of human Fas mRNA species upon peripheral blood mononuclear cell activation. Biochem. J. 310:1995;957-963.
23. Meazza R., Verdiani S., Biassoni R., Coppolecchia M., Gaggero A., Orengo A.M., Colombo M.P., Azzarone B., Ferrini S. Identification of a novel interleukin-15 (IL-15) transcript isoform generated by alternative splicing in human small cell lung cancer cell lines. Oncogene. 12:1996;2187-2192.
24. Miura T., Shibuya M., Tsujimoto H., Fukasawa M., Hayami M. Molecular cloning of a feline leukaemia provirus integrated adjacent to the c-myc gene in a feline T-cell leukaemia cell line and the unique structure of its long terminal repeat. Virology. 169:1989;458-461.
25. Miura T., Tsujimoto H., Fukasawa M., Kodama T., Shibuya M., Hasegawa A., Hayami M. Structural abnormality and over-expression of the myc gene in feline leukemias. Int. J. Cancer. 40:1987;564-569.
26. Momoi Y., Takuya M., Nishimura Y., Endo Y., Ohno K., Watari T., Goitsuka R., Tsujimoto H., Hasegawa A. Detection of apoptosis induced in peripheral blood lymphocytes from cats infected with feline immunodeficiency virus. Arch. Virol. 141:1996;1651-1659.
27. Oehm A., Behrmann I., Falk W., Pawlita M., Maier G., Klas C., Li-Weber M., Richards S., Dhein J., Trauth B.C.et al. Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen. J. Biol. Chem. 267:1992;10709-10715.
28. Ogasawara J., Watanabe-Fukunaga R., Adachi M., Matsuzawa A., Kasugai T., Kitamura Y., Itoh N., Suda T., Nagata S. Lethal effect of the anti-Fas antibody in mice. Nature. 364:1993;806-809.
29. Ohno K., Nakano T., Matsumoto Y., Watari T., Goitsuka R., Nakayama H., Tsujimoto H., Hasegawa A. Apoptosis induced by tumor necrosis factor in cells chronically infected with feline immunodeficiency virus. J. Virol. 67:1993;2429-2433.
30. Ohno K., Okamoto Y., Miyazawa T., Mikami T., Watari T., Goitsuka R., Tsujimoto H., Hasegawa A. Induction of apoptosis in a T lymphoblastoid cell line infected with feline immunodeficiency virus. Arch. Virol. 135:1994;153-158.
31. Oppenheim R.W. Cell death during development of the nervous system. Annu. Rev. Neurosci. 14:1991;453-501.
32. Raff M.C. Social controls on cell survival and cell death. Nature. 356:1992;397-400.
33. Rao L., Debbas M., Sabbatini P., Hockenbery D., Korsmeyer S., White E. The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteins. Proc. Natl. Acad. Sci. USA. 89:1992;7742-7746.
34. Ren R., Mayer B.J., Cicchetti P., Baltimore D. Identification of a ten-amino acid proline-rich SH3 binding site. Science. 259:1993;1157-1161.
35. Rieux-Laucat F., Le Deist F., Hivroz C., Roberts I.A., Debatin K.M., Fischer A., de Villartay J.P. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science. 268:1995;1347-1349.
36. Rouvier E., Luciani M.F., Golstein P. Fas involvement in Ca(2+)-independent T cell-mediated cytotoxicity. J. Exp. Med. 177:1993;195-200.
37. Snyder H.W. Jr., Hardy W.D. Jr., Zuckerman E.E., Fleissner E. Characterisation of a tumour-specific antigen on the surface of feline lymphosarcoma cells. Nature. 275:1978;656-658.
38. Suda T., Takahashi T., Golstein P., Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell. 75:1993;1169-1178.
39. Takahashi, T., Tanaka, M., Brannan, C.I., Jenkins, N.A., Copeland, N.G., Suda, T., Nagata, S., 1994a. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76, 969-976.
40. Takahashi, T., Tanaka, M., Inazawa, J., Abe, T., Suda, T., Nagata, S., 1994b. Human Fas ligand: gene structure, chromosomal location and species specificity. Int. Immunol. 6, 1567-1574.
41. Takizawa T., Fukuda R., Miyawaki T., Ohashi K., Nakanishi Y. Activation of the apoptotic Fas antigen-encoding gene upon influenza virus infection involving spontaneously produced beta-interferon. Virology. 209:1995;288-296.
42. Tanaka M., Suda T., Takahashi T., Nagata S. Expression of the functional soluble form of human fas ligand in activated lymphocytes. EMBO J. 14:1995;1129-1135.
43. Tartaglia L.A., Ayres T.M., Wong G.H., Goeddel D.V. A novel domain within the 55 kd TNF receptor signals cell death. Cell. 74:1993;845-853.
44. Tsytsikov V.N., Yurovsky V.V., Atamas S.P., Alms W.J., White B. Identification and characterization of two alternative splice variants of human interleukin-2. J. Biol. Chem. 271:1996;23055-23060.
45. Wada N., Matsumura M., Ohba Y., Kobayashi N., Takizawa T., Nakanishi Y. Transcription stimulation of the Fas-encoding gene by nuclear factor for interleukin-6 expression upon influenza virus infection. J. Biol. Chem. 270:1995;18007-18012.
46. Watanabe-Fukunaga R., Brannan C.I., Itoh N., Yonehara S., Copeland N.G., Jenkins N.A., Nagata S. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J. Immunol. 148:1992;1274-1279.
47. Westendorp M.O., Frank R., Ochsenbauer C., Stricker K., Dhein J., Walczak H., Debatin K.M., Krammer P.H. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature. 375:1995;497-500.
48. Yoo J., Stone R.T., Beattie C.W. Cloning and characterization of the bovine Fas. DNA. Cell Biol. 15:1996;227-234.